Carbapenem-Resistant Acinetobacter baumannii / 대한임상미생물학회지
Korean Journal of Clinical Microbiology
;
: 1-8, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-75747
ABSTRACT
Clinical isolates of Acinetobacter spp. in Korea exhibit higher antimicrobial resistance rates than in foreign countries and frequently show multi-drug resistance. Approximately 67% (272/405) of Acinetobacter baumannii isolates collected from 19 hospitals in Korea in 2008 exhibited intermediate susceptibility or resistance to imipenem and/or meropenem. The most important mechanisms in acquiring carbapenem resistance in A. baumannii in Korea are production of OXA-23 and overproduction of OXA-51, while that in non-baumannii Acinetobacter is the production of metallo-beta-lactamases. All the carbapenem-resistant A. baumannii isolates were identified as clonal complex 92 and belonged to worldwide clone 2.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Acinetobacter
/
Tienamicinas
/
Imipenem
/
Células Clonales
/
Resistencia a Múltiples Medicamentos
/
Acinetobacter baumannii
/
Corea (Geográfico)
País/Región como asunto:
Asia
Idioma:
Coreano
Revista:
Korean Journal of Clinical Microbiology
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS